See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $170B | 0.4x | 10.2x | |
| $24.9B | 6.9x | 28.9x | |
| $23.1B | n/a | n/a | |
| $18.7B | 1.9x | 31.4x | |
| $11.7B | 0.3x | 5.2x | |
| $10.4B | 2.2x | 34.3x | |
| $8.9B | 1.1x | 13.1x | |
| $8.8B | 0.7x | 14.4x | |
| $6.8B | 1.0x | 9.9x | |
| $4.9B | 1.7x | 12.4x | |
| $4.2B | 0.5x | 10.1x | |
| $4.2B | 0.5x | 11.0x | |
| $4.1B | 0.6x | 9.1x | |
| $4.1B | 1.5x | 9.1x | |
| $3.9B | 0.6x | 9.0x | |
| $3.8B | 0.6x | 9.3x | |
| $3.5B | 1.0x | 8.6x | |
| $3.4B | 0.1x | 4.9x | |
| $3.2B | 0.6x | 7.7x | |
| $2.8B | 0.8x | 11.3x | |
| $2.7B | 0.7x | 6.0x | |
| $2.7B | 0.4x | 4.8x | |
| $2.1B | 0.7x | 6.9x | |
| $2.0B | 0.8x | 10.3x | |
| $1.9B | 1.1x | 8.0x | |
| $1.6B | 1.4x | 11.4x | |
| $1.6B | 0.4x | 6.1x | |
| $1.5B | 0.4x | 21.4x | |
| $1.5B | 0.4x | 21.4x | |
| $1.3B | 0.5x | 8.6x | |
| $1.2B | 1.5x | 4.4x | |
| $1.2B | 0.4x | n/a | |
| $1.1B | n/a | n/a | |
| $1.1B | 0.8x | 10.5x | |
| $1.1B | 1.5x | 17.9x | |
| $1.0B | n/a | n/a | |
| $990M | 0.4x | 9.0x | |
| $947M | n/a | n/a | |
| $859M | 0.2x | 6.8x | |
| $842M | n/a | n/a | |
| $725M | n/a | n/a | |
| $624M | 1.0x | 11.2x | |
| $589M | n/a | n/a | |
| $484M | n/a | n/a | |
| $449M | 0.4x | 6.4x | |
| $386M | 0.3x | -6.8x | |
| $377M | n/a | n/a | |
| $364M | 0.1x | 12.7x | |
| $281M | n/a | n/a | |
| $275M | 0.2x | n/a | |
| $240M | 0.6x | 9.1x | |
| $127M | n/a | n/a | |
| $114M | n/a | n/a | |
| $90.1M | n/a | n/a | |
| $84.0M | 0.6x | 23.4x | |
| $50.7M | n/a | n/a | |
| $24.7M | n/a | n/a | |
| $20.8M | 0.3x | -100.4x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies